先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
1 credit a month to buy any audiobook in our entire collection.
Access to thousands of additional audiobooks and Originals from the Plus Catalogue.
Member-only deals & discounts.
Auto-renews at $16.45/mo after 30 days. Cancel anytime.
先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)
Narrated by:
海老塚 久蔵
Buy Now for $12.99
-
Narrated by:
-
海老塚 久蔵
-
By:
-
週刊東洋経済編集部
About this listen
２０１８年、世界のベンチャーキャピタルによるバイオテクノロジー分野への投資額は約１・７兆円に達し、１０年で７倍近くに膨らんだ。ゲノム解読費用が急減し、ビッグデータの活用で、患者一人ひとりに合わせた医療を提供する「プレシジョン・メディシン」の到来だ。製薬業界でもバイオベンチャーが開発した遺伝子治療薬やウイルス製剤などが希少疾患で成果を上げ、Ｍ＆Ａや提携も活発化している。次世代における医療の覇者は誰か。最先端ベンチャーを通して、未来をのぞく。
本誌は『週刊東洋経済』２０１９年４月２０日号掲載の２６ページ分を電子化したものです。©東洋経済新報社 (P)2020 Audible, Inc.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.